ABBV
AbbVie Inc. Common Stock
$186.07
Price of AbbVie stock today
The current price of ABBV is $186.07, with a market capitalization of $318,417.1. ABBV shares are listed on the NYSE stock exchange.
About AbbVie Inc.
AbbVie is a global biopharmaceutical company specializing in the development and commercialization of innovative medicines. With leading products in the treatment of autoimmune diseases, cancer, and other conditions, AbbVie has established itself as a major player in the pharmaceutical sector.
Is AbbVie a good investment?
AbbVie is considered a good investment due to its strong product portfolio and ability to generate stable revenue, particularly with drugs like Humira. Additionally, its focus on research and development of new treatments positions it as a company with long-term growth potential. However, patent expirations and competition in the sector are significant risks.
How has AbbVie stock performed historically?
AbbVie stock has shown consistent growth driven by its strong position in the biopharmaceutical market. With a strategy focused on innovation, the company has maintained robust profitability, offering attractive dividends to investors. Despite its success, like all investments, past performance does not guarantee future results.
!Ups! Sometimes wrong
Key Stats
Analyst Recommendations
Frequently Asked Questions (FAQ)




Sign up on Hapi
Download the Hapi app from Google Playstore or the App Store, or from the website. Sign up by completing all the steps of the form and verify your identity.
Add funds to your Hapi account
Make an initial deposit to your account. There are no minimum amounts, allowing you to start with any amount.
Choose how much to invest in stocks
Use the search function in Hapi to find your favorite stocks. Then select "Buy", review the price, and confirm your purchase.
Manage all your investments in one place
Access your portfolio through the Hapi app or web version and monitor the performance of your stocks. You can easily buy and sell your stocks whenever you want.
Categories
Similar assets
Trending Stocks
Trending ETFs
News

¡Ups! Algo salió mal
Hubo un problema al cargar la información.
Verifica tu conexión e inténtalo nuevamente.